Arena Pharmaceuticals, Inc. Income (Loss) from Continuing Operations, Per Basic Share
Arena Pharmaceuticals, Inc. reported Income (Loss) from Continuing Operations, Per Basic Share of -$7.39 per share for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-23.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerBasicShare · last filed 2021-02-23
- Arena Pharmaceuticals, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2019-09-30 was -$1.46.
- Arena Pharmaceuticals, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2019-06-30 was -$1.24.
- Arena Pharmaceuticals, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2019-03-31 was $12.53.
- Arena Pharmaceuticals, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2018-12-31 was $1.39.
- Arena Pharmaceuticals, Inc. income (loss) from continuing operations, per basic share for fiscal 2020 was -$7.39, a 192.49% decline from fiscal 2019.
- Arena Pharmaceuticals, Inc. income (loss) from continuing operations, per basic share for fiscal 2019 was $7.99.
- Arena Pharmaceuticals, Inc. income (loss) from continuing operations, per basic share for fiscal 2018 was -$0.61.
- Arena Pharmaceuticals, Inc. income (loss) from continuing operations, per basic share for fiscal 2017 was -$2.87.
| Period end | Income (Loss) from Continuing Operations, Per Basic Share 3 month | Income (Loss) from Continuing Operations, Per Basic Share 6 month | Income (Loss) from Continuing Operations, Per Basic Share 9 month | Income (Loss) from Continuing Operations, Per Basic Share 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$7.39 10-K · filed 2021-02-23 | |||
| 2019-12-31 | $7.99 10-K · filed 2021-02-23 | |||
| 2019-09-30 | -$1.46 10-Q · filed 2019-11-08 | $9.78 10-Q · filed 2019-11-08 | ||
| 2019-06-30 | -$1.24 10-Q · filed 2019-08-09 | $11.27 10-Q · filed 2019-08-09 | ||
| 2019-03-31 | $12.53 10-Q · filed 2019-05-09 | |||
| 2018-12-31 | $1.39 10-K · filed 2020-02-27 | -$0.61 10-K · filed 2021-02-23 | ||
| 2018-09-30 | -$0.70 10-K · filed 2020-02-27 | -$2.10 10-Q · filed 2019-11-08 | ||
| 2018-06-30 | -$0.65 10-K · filed 2020-02-27 | -$1.41 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | -$0.78 10-K · filed 2020-02-27 | |||
| 2017-12-31 | -$2.87 10-K · filed 2020-02-27 | |||
| 2016-12-31 | $2.02 10-K · filed 2018-03-14 | |||
| 2016-09-30 | -$0.50 10-K · filed 2018-03-14 | |||
| 2016-06-30 | -$1.18 10-K · filed 2018-03-14 | |||
| 2016-03-31 | -$0.83 10-K · filed 2018-03-14 |